{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:42:58Z","timestamp":1790311378646,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,6,13]],"date-time":"2016-06-13T00:00:00Z","timestamp":1465776000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2016,6,13]],"date-time":"2016-06-13T00:00:00Z","timestamp":1465776000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1 AI068636"],"award-info":[{"award-number":["UM1 AI068636"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1 AI106701"],"award-info":[{"award-number":["UM1 AI106701"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 GM008719"],"award-info":[{"award-number":["T32 GM008719"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["F30 MH098731"],"award-info":[{"award-number":["F30 MH098731"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12879-016-1611-2","type":"journal-article","created":{"date-parts":[[2016,6,13]],"date-time":"2016-06-13T12:08:42Z","timestamp":1465819722000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Predicting resistance as indicator for need to switch from first-line antiretroviral therapy among patients with elevated viral loads: development of a risk score algorithm"],"prefix":"10.1186","volume":"16","author":[{"given":"Sarah E.","family":"Rutstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina C.","family":"Hosseinipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morris","family":"Weinberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie B.","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea K.","family":"Biddle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole L.","family":"Wallis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pachamuthu","family":"Balakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Mellors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariza","family":"Morgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanmugam","family":"Saravanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srikanth","family":"Tripathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saran","family":"Vardhanabhuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph J.","family":"Eron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,13]]},"reference":[{"key":"1611_CR1","volume-title":"Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection","author":"WHO","year":"2013","unstructured":"WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Geneva: WHO; 2013."},{"issue":"9","key":"1611_CR2","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1097\/QAD.0b013e32832ac34e","volume":"23","author":"MC Hosseinipour","year":"2009","unstructured":"Hosseinipour MC, van Oosterhout JJ, Weigel R, Phiri S, Kamwendo D, Parkin N, Fiscus SA, Nelson JA, Eron JJ, Kumwenda J. The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy. AIDS. 2009;23(9):1127\u201334.","journal-title":"AIDS"},{"issue":"9","key":"1611_CR3","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.2165\/11633630-000000000-00000","volume":"72","author":"MW Tang","year":"2012","unstructured":"Tang MW, Shafer RW. HIV-1 antiretroviral resistance: scientific principles and clinical applications. Drugs. 2012;72(9):e1\u201325.","journal-title":"Drugs"},{"issue":"15","key":"1611_CR4","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1097\/QAD.0b013e32830e4cd8","volume":"22","author":"P Mee","year":"2008","unstructured":"Mee P, Fielding KL, Charalambous S, Churchyard GJ, Grant AD. Evaluation of the WHO criteria for antiretroviral treatment failure among adults in South Africa. AIDS (London, England). 2008;22(15):1971\u20137.","journal-title":"AIDS (London, England)"},{"issue":"1","key":"1611_CR5","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1086\/648590","volume":"201","author":"N Ndembi","year":"2010","unstructured":"Ndembi N, Goodall RL, Dunn DT, McCormick A, Burke A, Lyagoba F, Munderi P, Katundu P, Kityo C, Robertson V, et al. Viral rebound and emergence of drug resistance in the absence of viral load testing: a randomized comparison between zidovudine-lamivudine plus Nevirapine and zidovudine-lamivudine plus Abacavir. J Infect Dis. 2010;201(1):106\u201313.","journal-title":"J Infect Dis"},{"issue":"2","key":"1611_CR6","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1086\/600044","volume":"49","author":"N Kumarasamy","year":"2009","unstructured":"Kumarasamy N, Madhavan V, Venkatesh KK, Saravanan S, Kantor R, Balakrishnan P, Devaleenal B, Poongulali S, Yepthomi T, Solomon S, et al. High frequency of clinically significant mutations after first-line generic highly active antiretroviral therapy failure: implications for second-line options in resource-limited settings. Clin Infect Dis. 2009;49(2):306\u20139.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1611_CR7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1093\/jac\/dkh012","volume":"53","author":"R de la Rosa","year":"2004","unstructured":"de la Rosa R, Ruiz-Mateos E, Rubio A, Abad MA, Vallejo A, Rivero L, Genebat M, Sanchez-Quijano A, Lissen E, Leal M. Long-term virological outcome and resistance mutations at virological rebound in HIV-infected adults on protease inhibitor-sparing highly active antiretroviral therapy. J Antimicrob Chemother. 2004;53(1):95\u2013101.","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"1611_CR8","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S1473-3099(09)70136-7","volume":"9","author":"RK Gupta","year":"2009","unstructured":"Gupta RK, Hill A, Sawyer AW, Cozzi-Lepri A, von Wyl V, Yerly S, Lima VD, Gunthard HF, Gilks C, Pillay D. Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysis. Lancet Infect Dis. 2009;9(7):409\u201317.","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"1611_CR9","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1468-1293.2010.00825.x","volume":"11","author":"MC Hosseinipour","year":"2010","unstructured":"Hosseinipour MC, Kumwenda JJ, Weigel R, Brown LB, Mzinganjira D, Mhango B, Eron JJ, Phiri S, van Oosterhout JJ. Second-line treatment in the Malawi antiretroviral programme: high early mortality, but good outcomes in survivors, despite extensive drug resistance at baseline. HIV Med. 2010;11(8):510\u20138.","journal-title":"HIV Med"},{"issue":"7","key":"1611_CR10","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1097\/00002030-200404300-00005","volume":"18","author":"AC Karlsson","year":"2004","unstructured":"Karlsson AC, Younger SR, Martin JN, Grossman Z, Sinclair E, Hunt PW, Hagos E, Nixon DF, Deeks SG. Immunologic and virologic evolution during periods of intermittent and persistent low-level viremia. AIDS. 2004;18(7):981\u20139.","journal-title":"AIDS"},{"issue":"10","key":"1611_CR11","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1086\/587109","volume":"46","author":"VC Marconi","year":"2008","unstructured":"Marconi VC, Sunpath H, Lu Z, Gordon M, Koranteng-Apeagyei K, Hampton J, Carpenter S, Giddy J, Ross D, Holst H, et al. Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa. Clin Infect Dis. 2008;46(10):1589\u201397.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"1611_CR12","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1097\/QAD.0b013e3282fa75b9","volume":"22","author":"M Pujades-Rodriguez","year":"2008","unstructured":"Pujades-Rodriguez M, O\u2019Brien D, Humblet P, Calmy A. Second-line antiretroviral therapy in resource-limited settings: the experience of Medecins Sans Frontieres. AIDS. 2008;22(11):1305\u201312.","journal-title":"AIDS"},{"issue":"2","key":"1611_CR13","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/135965350901400211","volume":"14","author":"SJ Reynolds","year":"2009","unstructured":"Reynolds SJ, Kityo C, Mbamanya F, Dewar R, Ssali F, Quinn TC, Mugyenyi P, Dybul M. Evolution of drug resistance after virological failure of a first-line highly active antiretroviral therapy regimen in Uganda. Antivir Ther. 2009;14(2):293\u20137.","journal-title":"Antivir Ther"},{"issue":"14","key":"1611_CR14","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1097\/QAD.0b013e328349822f","volume":"25","author":"O Keiser","year":"2011","unstructured":"Keiser O, Chi BH, Gsponer T, Boulle A, Orrell C, Phiri S, Maxwell N, Maskew M, Prozesky H, Fox MP, et al. Outcomes of antiretroviral treatment in programmes with and without routine viral load monitoring in Southern Africa. AIDS. 2011;25(14):1761\u20139.","journal-title":"AIDS"},{"issue":"2","key":"1611_CR15","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/j.1365-3156.2009.02445.x","volume":"15","author":"O Keiser","year":"2010","unstructured":"Keiser O, Tweya H, Braitstein P, Dabis F, MacPhail P, Boulle A, Nash D, Wood R, Luthi R, Brinkhof MW, et al. Mortality after failure of antiretroviral therapy in sub-Saharan Africa. Trop Med Int Health. 2010;15(2):251\u20138.","journal-title":"Trop Med Int Health"},{"key":"1611_CR16","volume-title":"Access to Antireretroviral Therapy in Africa: Status report on progress towards the 2015 targets","author":"UNAIDS","year":"2013","unstructured":"UNAIDS. Access to Antireretroviral Therapy in Africa: Status report on progress towards the 2015 targets. Geneva: UNAIDS; 2013."},{"issue":"6","key":"1611_CR17","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.trstmh.2008.11.007","volume":"103","author":"D Wilson","year":"2009","unstructured":"Wilson D, Keiluhu AK, Kogrum S, Reid T, Seriratana N, Ford N, Kyawkyaw M, Talangsri P, Taochalee N. HIV-1 viral load monitoring: an opportunity to reinforce treatment adherence in a resource-limited setting in Thailand. Trans R Soc Trop Med Hyg. 2009;103(6):601\u20136.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"4","key":"1611_CR18","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1097\/QAI.0b013e3182557785","volume":"60","author":"MP Fox","year":"2012","unstructured":"Fox MP, Cutsem GV, Giddy J, Maskew M, Keiser O, Prozesky H, Wood R, Hernan MA, Sterne JA, Egger M, et al. Rates and predictors of failure of first-line antiretroviral therapy and switch to second-line ART in South Africa. J Acquir Immune Defic Syndr. 2012;60(4):428\u201337.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"1611_CR19","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1097\/QAD.0b013e328333bfb7","volume":"24","author":"A Boulle","year":"2010","unstructured":"Boulle A, Van Cutsem G, Hilderbrand K, Cragg C, Abrahams M, Mathee S, Ford N, Knight L, Osler M, Myers J, et al. Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa. AIDS. 2010;24(4):563\u201372.","journal-title":"AIDS"},{"issue":"5","key":"1611_CR20","doi-asserted-by":"publisher","first-page":"377","DOI":"10.2471\/BLT.12.112946","volume":"91","author":"JH McMahon","year":"2013","unstructured":"McMahon JH, Elliott JH, Bertagnolio S, Kubiak R, Jordan MR. Viral suppression after 12\u00a0months of antiretroviral therapy in low- and middle-income countries: a systematic review. Bull World Health Organ. 2013;91(5):377\u2013385E.","journal-title":"Bull World Health Organ"},{"key":"1611_CR21","unstructured":"HIV\/AIDS [ http:\/\/www.who.int\/mediacentre\/factsheets\/fs360\/en\/ ]. Accessed 21 Oct 2015."},{"issue":"8","key":"1611_CR22","doi-asserted-by":"publisher","first-page":"e1001290","DOI":"10.1371\/journal.pmed.1001290","volume":"9","author":"TB Campbell","year":"2012","unstructured":"Campbell TB, Smeaton LM, Kumarasamy N, Flanigan T, Klingman KL, Firnhaber C, Grinsztejn B, Hosseinipour MC, Kumwenda J, Lalloo U, et al. Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: a randomized clinical trial in diverse multinational settings. PLoS Med. 2012;9(8):e1001290.","journal-title":"PLoS Med"},{"issue":"10","key":"1611_CR23","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/cid\/civ102","volume":"60","author":"R Kantor","year":"2015","unstructured":"Kantor R, Smeaton L, Vardhanabhuti S, Hudelson SE, Wallis CL, Tripathy S, Morgado MG, Saravanan S, Balakrishnan P, Reitsma M, et al. Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated With Virologic Failure: Results From the Multinational PEARLS (ACTG A5175) Clinical Trial. Clin Infect Dis. 2015;60(10):1541\u20139.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"1611_CR24","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1001\/jama.300.5.555","volume":"300","author":"SM Hammer","year":"2008","unstructured":"Hammer SM, Eron Jr JJ, Reiss P, Schooley RT, Thompson MA, Walmsley S, Cahn P, Fischl MA, Gatell JM, Hirsch MS. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. JAMA. 2008;300(5):555\u201370.","journal-title":"JAMA"},{"key":"1611_CR25","unstructured":"Clinical Guidelines for the Management of HIV&AIDS in Adults and Adolescents. Pretoria: National Department of Health; 2010. http:\/\/www.who.int\/hiv\/pub\/guidelines\/south_africa_art.pdf . Accessed 7 June 2016."},{"key":"1611_CR26","unstructured":"Clinical Management of HIV in Children and Adults. First edition. Lilongwe: Ministry of Health, Malawi; 2011. http:\/\/apps.who.int\/medicinedocs\/documents\/s18802en\/s18802en.pdf . Accessed 7 June 2016."},{"key":"1611_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-3462-1","volume-title":"Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis","author":"F Harrell","year":"2001","unstructured":"Harrell F. Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis. New York: Springer; 2001."},{"issue":"8","key":"1611_CR28","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/0895-4356(96)00025-X","volume":"49","author":"GW Sun","year":"1996","unstructured":"Sun GW, Shook TL, Kay GL. Inappropriate use of bivariable analysis to screen risk factors for use in multivariable analysis. J Clin Epidemiol. 1996;49(8):907\u201316.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"1611_CR29","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.0006-341X.2001.00120.x","volume":"57","author":"W Pan","year":"2001","unstructured":"Pan W. Akaike\u2019s information criterion in generalized estimating equations. Biometrics. 2001;57(1):120\u20135.","journal-title":"Biometrics"},{"issue":"6","key":"1611_CR30","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1001\/jama.1997.03540300056034","volume":"277","author":"A Laupacis","year":"1997","unstructured":"Laupacis A, Sekar N, Stiell IG. Clinical prediction rules. A review and suggested modifications of methodological standards. JAMA. 1997;277(6):488\u201394.","journal-title":"JAMA"},{"issue":"11","key":"1611_CR31","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.jclinepi.2008.04.008","volume":"61","author":"DB Toll","year":"2008","unstructured":"Toll DB, Janssen KJ, Vergouwe Y, Moons KG. Validation, updating and impact of clinical prediction rules: a review. J Clin Epidemiol. 2008;61(11):1085\u201394.","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"1611_CR32","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837\u201345.","journal-title":"Biometrics"},{"issue":"7305","key":"1611_CR33","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1136\/bmj.323.7305.157","volume":"323","author":"JJ Deeks","year":"2001","unstructured":"Deeks JJ. Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests. BMJ. 2001;323(7305):157\u201362.","journal-title":"BMJ"},{"issue":"8","key":"1611_CR34","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.jclinepi.2007.08.014","volume":"61","author":"KJ McClamroch","year":"2008","unstructured":"McClamroch KJ, Kaufman JS, Behets FM. A formal decision analysis identifies an optimal treatment strategy in a resource-poor setting. J Clin Epidemiol. 2008;61(8):776\u201387.","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"1611_CR35","doi-asserted-by":"publisher","first-page":"201","DOI":"10.7326\/0003-4819-144-3-200602070-00009","volume":"144","author":"BM Reilly","year":"2006","unstructured":"Reilly BM, Evans AT. Translating clinical research into clinical practice: impact of using prediction rules to make decisions. Ann Intern Med. 2006;144(3):201\u20139.","journal-title":"Ann Intern Med"},{"issue":"4","key":"1611_CR36","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","volume":"15","author":"FE Harrell Jr","year":"1996","unstructured":"Harrell Jr FE, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15(4):361\u201387.","journal-title":"Stat Med"},{"issue":"4","key":"1611_CR37","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5","volume":"19","author":"DG Altman","year":"2000","unstructured":"Altman DG, Royston P. What do we mean by validating a prognostic model? Stat Med. 2000;19(4):453\u201373.","journal-title":"Stat Med"},{"issue":"8","key":"1611_CR38","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/S0895-4356(01)00341-9","volume":"54","author":"EW Steyerberg","year":"2001","unstructured":"Steyerberg EW, Harrell Jr FE, Borsboom GJ, Eijkemans MJ, Vergouwe Y, Habbema JD. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol. 2001;54(8):774\u201381.","journal-title":"J Clin Epidemiol"},{"issue":"15","key":"1611_CR39","doi-asserted-by":"publisher","first-page":"3301","DOI":"10.1093\/bioinformatics\/bti499","volume":"21","author":"AM Molinaro","year":"2005","unstructured":"Molinaro AM, Simon R, Pfeiffer RM. Prediction error estimation: a comparison of resampling methods. Bioinformatics. 2005;21(15):3301\u20137.","journal-title":"Bioinformatics"},{"issue":"382","key":"1611_CR40","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1080\/01621459.1983.10477973","volume":"78","author":"B Efron","year":"1983","unstructured":"Efron B. Estimating the error rate of a prediction rule: improvement on cross-validation. J Am Stat Assoc. 1983;78(382):316\u201330.","journal-title":"J Am Stat Assoc"},{"key":"1611_CR41","volume-title":"International Joint Conference on Artificial Intelligence","author":"R Kohavi","year":"1995","unstructured":"Kohavi R. A Study of Cross-Validation and Bootstrap for Accuracy Estimation and Model Selection. In: International Joint Conference on Artificial Intelligence. 1995."},{"key":"1611_CR42","doi-asserted-by":"crossref","unstructured":"Hosmer DW, Lemeshow S. Applied Logistic Regression. 2nd edition. Hoboken, New Jersey: John Wiley & Sons, Inc; 2000.","DOI":"10.1002\/0471722146"},{"issue":"11","key":"1611_CR43","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1111\/j.1365-3156.2012.03073.x","volume":"17","author":"MA Davies","year":"2012","unstructured":"Davies MA, Boulle A, Technau K, Eley B, Moultrie H, Rabie H, Garone D, Giddy J, Wood R, Egger M, et al. The role of targeted viral load testing in diagnosing virological failure in children on antiretroviral therapy with immunological failure. Trop Med Int Health. 2012;17(11):1386\u201390.","journal-title":"Trop Med Int Health"},{"issue":"2","key":"1611_CR44","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1093\/cid\/ciq084","volume":"52","author":"GU van Zyl","year":"2011","unstructured":"van Zyl GU, Preiser W, Potschka S, Lundershausen AT, Haubrich R, Smith D. Pooling strategies to reduce the cost of HIV-1 RNA load monitoring in a resource-limited setting. Clin Infect Dis. 2011;52(2):264\u201370.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"1611_CR45","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1097\/QAI.0b013e3181ff63d7","volume":"56","author":"MW Tilghman","year":"2011","unstructured":"Tilghman MW, Guerena DD, Licea A, Perez-Santiago J, Richman DD, May S, Smith DM. Pooled nucleic acid testing to detect antiretroviral treatment failure in Mexico. J Acquir Immune Defic Syndr. 2011;56(3):e70\u20134.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"16","key":"1611_CR46","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1097\/QAD.0b013e3283313ca9","volume":"23","author":"DM Smith","year":"2009","unstructured":"Smith DM, May SJ, Perez-Santiago J, Strain MC, Ignacio CC, Haubrich RH, Richman DD, Benson CA, Little SJ. The use of pooled viral load testing to identify antiretroviral treatment failure. AIDS. 2009;23(16):2151\u20138.","journal-title":"AIDS"},{"key":"1611_CR47","doi-asserted-by":"crossref","unstructured":"Pannus P, Fajardo E, Metcalf C, Coulborn RM, Duran LT, Bygrave H, Ellman T, Garone D, Murowa M, Mwenda R. Pooled, et al. HIV-1 viral load testing using dried blood spots to reduce the cost of monitoring antiretroviral treatment in a resource-limited setting. J Acquir Immune Defic Syndr. 2013;64(2):134\u20137.","DOI":"10.1097\/QAI.0b013e3182a61e63"},{"issue":"1","key":"1611_CR48","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/S1473-3099(09)70321-4","volume":"10","author":"AD Harries","year":"2010","unstructured":"Harries AD, Zachariah R, van Oosterhout JJ, Reid SD, Hosseinipour MC, Arendt V, Chirwa Z, Jahn A, Schouten EJ, Kamoto K. Diagnosis and management of antiretroviral-therapy failure in resource-limited settings in sub-Saharan Africa: challenges and perspectives. Lancet Infect Dis. 2010;10(1):60\u20135.","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"1611_CR49","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jviromet.2004.02.015","volume":"119","author":"N Mackie","year":"2004","unstructured":"Mackie N, Dustan S, McClure MO, Weber JN, Clarke JR. Detection of HIV-1 antiretroviral resistance from patients with persistently low but detectable viraemia. J Virol Methods. 2004;119(2):73\u20138.","journal-title":"J Virol Methods"},{"issue":"5","key":"1611_CR50","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1097\/01.aids.0000216381.37679.69","volume":"20","author":"L Waters","year":"2006","unstructured":"Waters L, Mandalia S, Asboe D. Successful use of genotypic resistance testing in HIV-1-infected individuals with detectable viraemia between 50 and 1000 copies\/ml. AIDS. 2006;20(5):778\u20139.","journal-title":"AIDS"},{"issue":"8","key":"1611_CR51","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/j.1468-1293.2008.00607.x","volume":"9","author":"PA Cane","year":"2008","unstructured":"Cane PA, Kaye S, Smit E, Tilston P, Kirk S, Shepherd J, Hopkins M, Zhang H, Geretti AM. Genotypic antiretroviral drug resistance testing at low viral loads in the UK. HIV Med. 2008;9(8):673\u20136.","journal-title":"HIV Med"},{"issue":"8","key":"1611_CR52","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1093\/cid\/ciu019","volume":"58","author":"A Gonzalez-Serna","year":"2014","unstructured":"Gonzalez-Serna A, Min JE, Woods C, Chan D, Lima VD, Montaner JS, Harrigan PR, Swenson LC. Performance of HIV-1 drug resistance testing at low-level viremia and its ability to predict future virologic outcomes and viral evolution in treatment-naive individuals. Clin Infect Dis. 2014;58(8):1165\u201373.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"1611_CR53","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1093\/cid\/ciu020","volume":"58","author":"MM Santoro","year":"2014","unstructured":"Santoro MM, Fabeni L, Armenia D, Alteri C, Di Pinto D, Forbici F, Bertoli A, Di Carlo D, Gori C, Carta S. Reliability and clinical relevance of the HIV-1 drug resistance test in patients with low viremia levels. Clin Infect Dis. 2014;58(8):1156\u201364.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"1611_CR54","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1097\/QAD.0000000000000203","volume":"28","author":"LC Swenson","year":"2014","unstructured":"Swenson LC, Min JE, Woods CK, Cai E, Li JZ, Montaner JS, Harrigan PR, Gonzalez-Serna A. HIV drug resistance detected during low-level viraemia is associated with subsequent virologic failure. AIDS. 2014;28(8):1125\u201334.","journal-title":"AIDS"},{"issue":"11","key":"1611_CR55","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1093\/cid\/cis254","volume":"54","author":"RL Hamers","year":"2012","unstructured":"Hamers RL, Sigaloff KC, Wensing AM, Wallis CL, Kityo C, Siwale M, Mandaliya K, Ive P, Botes ME, Wellington M, et al. Patterns of HIV-1 drug resistance after first-line antiretroviral therapy (ART) failure in 6 sub-Saharan African countries: implications for second-line ART strategies. Clin Infect Dis. 2012;54(11):1660\u20139.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"1611_CR56","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1086\/648444","volume":"49","author":"CJ Hoffmann","year":"2009","unstructured":"Hoffmann CJ, Charalambous S, Sim J, Ledwaba J, Schwikkard G, Chaisson RE, Fielding KL, Churchyard GJ, Morris L, Grant AD. Viremia, resuppression, and time to resistance in human immunodeficiency virus (HIV) subtype C during first-line antiretroviral therapy in South Africa. Clin Infect Dis. 2009;49(12):1928\u201335.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1611_CR57","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1093\/cid\/cit627","volume":"58","author":"AF Aghokeng","year":"2014","unstructured":"Aghokeng AF, Monleau M, Eymard-Duvernay S, Dagnra A, Kania D, Ngo-Giang-Huong N, Toni TD, Toure-Kane C, Truong LX, Delaporte E, et al. Extraordinary heterogeneity of virological outcomes in patients receiving highly antiretroviral therapy and monitored with the World Health Organization public health approach in sub-saharan Africa and southeast Asia. Clin Infect Dis. 2014;58(1):99\u2013109.","journal-title":"Clin Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1611-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-016-1611-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1611-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1611-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T15:46:20Z","timestamp":1718639180000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-016-1611-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,13]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1611"],"URL":"https:\/\/doi.org\/10.1186\/s12879-016-1611-2","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,13]]},"assertion":[{"value":"10 December 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"280"}}